This search function provides links to outputs produced by NIHR Innovation Observatory. These are briefing notes or reports on new or repurposed technologies. This search will not return all technologies currently in development as these outputs are produced as required for our stakeholders.

Innovation Observatory > Reports > Drugs > Neridronic Acid (Nerixia) for Complex Regional Pain Syndrome

< Back

Neridronic Acid (Nerixia) for Complex Regional Pain Syndrome


Anaesthetics, Pain Relief and ITU

November 2017

The cause of CRPS is unknown, but it is generally thought to be the result of the body reacting abnormally to an injury. It is difficult to estimate exactly how common CRPS is, as many cases may go undiagnosed or misdiagnosed. Currently there are no approved treatments for CRPS. Neridronic acid administered by injection is currently being developed to treat CRPS and early results indicate that it has the possibility to control the condition. If approved neridronic acid will be a potential new treatment for CRPS.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Neridronic Acid for Complex Regional Pain Syndrome


Connect to the Innovation Observatory


Load More Related Posts

Get Alerts